1. Home
  2. Clinical Topics
  3. FDA approves Onfi for seizures associated with Lennox-Gastaut syndrome
Clinical TopicsDrugs and DevicesNeurologyNewsPediatricsWeb Exclusives

FDA approves Onfi for seizures associated with Lennox-Gastaut syndrome

Share

The U.S. Food and Drug Administration has approved Onfi (clobazam) for use as an adjunctive treatment for seizures associated with Lennox-Gastaut syndrome in adults and children 2 years of age and older. Read more.

Leave a Reply

Your email address will not be published.

Fill out this field
Fill out this field
Please enter a valid email address.

Get your free subscription to NurseLine!

NurseLine Newsletter

  • Hidden

*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.

Recent Posts